Colleen Moretti

Gefitinib plus chemotherapy could be considered a first-line treatment option for patients with EGFR-mutated NSCLC with brain metastases.

Triplet therapy demonstrates improved remission and survival rates, with manageable side effects for patients who are ineligible for transplant.

Patients with MPNs should consult with their treating physician to individualize a healthy, nutritious diet to help ease symptoms.

Patients and their caregivers may benefit from community support and education following an MPN diagnosis

PARP inhibitors, primarily used to treat BRCA-mutated disease, may have efficacy potential in triple negative breast cancer.

Recent results highlight that men with the disease have not lived as long as female patients have during the past three decades.

Although the pandemic prevented Branwyn Lee's family from being with her during cancer treatment, she never felt alone on her journey.

An expert discusses the impact on patients and families lacking equal access to counseling and testing.

Breast cancer treatment can disrupt patients’ quality and quantity of sleep, leaving them fatigued and restless during the day.

Eating a plant-based diet has been associated with sustained MRD negativity for patients with multiple myeloma.